Anticancer agent 270

• Description :

  Anticancer agent 270 (Compound 8e) is an inhibitor that acts on tubulin. Its IC50 value against MCF-7 breast cancer cells is 1.02 μM. Through a dual mechanism of action, namely inducing Apoptosis and destabilizing microtubules, it exerts significant anti-proliferative activity against breast cancer cells. Anticancer agent 270 can be applied to research in the field of cancer[1].

• UNSPSC :

  12352005

• Target :

  Microtubule/Tubulin

• Related Pathways :

  Cell Cycle/DNA Damage; Cytoskeleton

• Field of Research :

  Cancer

• Smiles :

  CC1=CC=C2C(C(C(C3=NN=C(SCC(C4=CC(OC)=C(OC)C(OC)=C4)=O)N3)=CO2)=O)=C1

• Molecular Formula :

  C23H21N3O6S

• Molecular Weight :

  467.49

• References & Citations :

  [1]Saadh M J, et al. Design and synthesis of chromene-triazole hybrids via recyclable magnetic nanocatalyst: Potent dual-acting anticancer agents targeting apoptotic and microtubule dynamics[J]. Journal of Molecular Structure, 2025, 1338: 142093.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported